Total N=286791
Men N=153987
Women N=132804
<55 years N=37221
55-74 years N=153250
≥75 years N=96320
<=2 years duration N=46923
3-5 years duration N=74383
6-10 years duration N=61052
>10 years duration
N=32509
eGFR ≥60 N=157305
eGFR 30-59 N=32597
eGFR <30 N=2266
Lifestyle Only
24.4
24.6
24.1
29.8
23.2
24.1
37.8
25.5
18.5
12.7
22.0
19.0
19.0
Metformin
41.2
41.7
40.5
44.7
44.3
34.9
43.8
41.8
40.6
36.6
45.8
36.4
16.2
Sulphonylurea
17.4
17.7
17.2
11.4
16.6
21.2
10.0
17.6
21.1
21.2
17.9
19.9
12.1
Glitazone
0.8
0.8
0.9
0.8
0.9
0.8
0.3
0.8
1.1
1.2
0.7
1.1
1.2
Glinide
2.4
2.4
2.4
1.7
2.3
2.9
1.5
2.5
2.8
2.8
2.1
3.6
8.0
Insulin
12.4
11.5
13.5
10.7
11.5
14.5
5.6
10.4
14.3
23.9
10.0
18.3
42.6
Other
a
1.4
1.3
1.4
1.0
1.3
1.6
1.0
1.4
1.5
1.5
1.3
1.6
0.9
a
Other: Alphaglucosidase inhibitor, DPP4 inhibitor or GLP-1 analog (exenatide)
eGFR: Estimated Glomerular Filtration Rate
Table 3:
Use of glycaemic-lowering drugs by age, sex, diabetes duration and renal function.
